Genworth Financial (GNW) Could Be 20% Below Fair Value As Earnings And Buybacks Land

Genworth Financial, Inc.

Genworth Financial, Inc.

GNW

0.00

Genworth Financial (GNW) has drawn fresh attention after reporting second quarter 2026 earnings alongside progress on its share repurchase program, giving investors new information on both profitability and capital returns.

Over the past year, Genworth Financial has seen the share price record an 11.71% year to date share price return and a 16.78% 1 year total shareholder return, while the 5 year total shareholder return of 187.93% points to strong longer term momentum. Recent earnings and buybacks are likely helping to sustain this performance.

If Genworth’s recent move has you thinking about where else capital may find long term opportunities, it could be worth scanning 19 top founder-led companies

Genworth Financial now trades about 20% below the average analyst target after steady earnings and active buybacks. Is this discount a signal that the market is too cautious, or a fair reflection of the risks investors still see?

Preferred P/E of 18.7x for Genworth Financial: Is it justified?

Genworth Financial currently trades on a P/E of 18.7x against a last close of $10.02, which positions the stock at a noticeably higher earnings multiple than many insurance peers.

The P/E ratio compares the company’s share price to its earnings per share, so it gives a quick sense of how much investors are paying today for each dollar of current earnings. For an insurer such as Genworth Financial, this is a common reference point because earnings quality, capital intensity, and balance sheet structure often differ from other sectors, making simple revenue based metrics less useful.

Statements show a mixed picture. On one hand, Genworth Financial’s P/E of 18.7x is slightly below the broader US market average of 19.2x, which points to a valuation that is roughly in line with the market overall. On the other hand, the same 18.7x P/E is described as expensive versus both the US Insurance industry average of 11.5x and a peer average of 10.9x, at the same time as earnings have declined by 40.5% per year over the past 5 years and return on equity is a modest 3.4%. That combination suggests the current multiple is materially richer than what similar insurance companies trade on.

Compared with the insurance industry and peer benchmarks, the gap is wide. A P/E of 18.7x sits well above industry levels around 11x and peer averages just under that. In the absence of a meaningful change in earnings or profitability metrics, the valuation multiple may be seen as full when set against those sector yardsticks.

Result: Price-to-earnings of 18.7x (OVERVALUED)

However, Genworth Financial still faces risks from its long term care insurance exposure and from any shift in mortgage credit quality that could pressure earnings and capital.

Next Steps

Given the mix of optimism and concern around Genworth Financial, it makes sense to review the full picture for yourself and act while the information is fresh. To weigh the potential rewards against the key issues that could hold the stock back, take a closer look at the 1 key reward and 2 important warning signs.

Looking for more investment ideas beyond Genworth Financial?

If Genworth Financial has sharpened your focus on valuation and risk, do not stop here. Broaden your watchlist now so you are not reacting after the best ideas move.

  • Target resilient companies with measured risk by scanning the 85 resilient stocks with low risk scores that could help balance more volatile positions in your portfolio.
  • Spot potential mispricings early by running through the 49 high quality undervalued stocks before the broader market pays closer attention.
  • Uncover lesser known opportunities with strong fundamentals by checking the screener containing 20 high quality undiscovered gems before they attract wider interest.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.